Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Connect with us

Hi, what are you looking for?

slide 3 of 2
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Business

Business

Syngenta’s $9.5 billion IPO nears with Shanghai bourse hearing.

Syngenta Logo Photo Credit: ARND WIEGMANN Syngenta Logo Photo Credit: ARND WIEGMANN
Syngenta Logo Photo Credit: ARND WIEGMANN Syngenta Logo Photo Credit: ARND WIEGMANN

Listen to the article now

The Shanghai Stock Exchange will hear about Syngenta’s $9.5 billion IPO next week.

Syngenta, a competitor of Corteva (CTVA.N), BASF (BASFn.DE), and Bayer (BAYGn.DE), was acquired by ChemChina for $43 billion in 2017 and merged into Sinochem Holdings Corp in 2021.

With Syngenta’s $50 billion IPO, the Chinese parent expects to retain a controlling interest.

On Wednesday, the Shanghai Stock Exchange announced a March 29 hearing for the company’s listing application. Syngenta also amended its prospectus.

The offering seeks to raise 65 billion yuan, or $9.44 billion.

Acquisitions and debt repayment will account for 60% of the proceeds.

The prospectus allocates 20% to advanced agriculture technology research and development.

Syngenta’s IPO will need CSRC registration after the hearing.

Two sources said the business plans to offer in June, seeking mostly Chinese key shareholders.

Chinese market laws prevented Syngenta from commenting.

After Ant Group’s 2020 delisting, the four-year-old STAR board’s biggest float will certainly boost it.

Refinitiv Eikon statistics show that the Nasdaq-style STAR Market raised $28.5 billion in 2022.

The Shanghai bourse reviewed Syngenta’s listing proposal three times since July 2021.

Wednesday saw the company’s biggest yearly revenues and profitability. Sales climbed 19% to $33.4 billion, and EBITDA rose 20% to $5.6 billion in 2022.

The corporation added 136 additional Modern Agriculture Platform centers in China, bringing its total to 628.

“All business divisions achieved double-digit growth, benefiting from robust demand for products and services aimed to boost yield improvements and sustainable farming,” Syngenta stated.

Higher raw material costs hurt its fourth-quarter earnings. It spent more on corporate reorganization and saved for macroeconomic risks.

Seed sales drove revenues up 4% to $7.5 billion and EBITDA down 25% to $900 million.

“As previously mentioned, farmers expedited their purchases earlier in the year owing to supply worries, reducing fourth quarter growth,” the business said.


Comment Template

You May Also Like

Business

In response to recent US tariffs on Canadian goods, Ontario imposed a 25% levy on electricity exports to New York, Michigan, and Minnesota. This...

Business

Major US market indices fell significantly, with the S&P 500 reaching a six-month low. This slump coincides with growing concerns about a probable US...

Business

**Excerpt:** Bong Joon-ho’s *Mickey 17* is a sci-fi masterpiece that cements his status as one of the most visionary filmmakers of our time. Starring...

Business

**Excerpt:** Bong Joon-ho, the visionary director behind *Parasite*, returns with *Mickey 17*, a sci-fi thriller based on Edward Ashton’s novel *Mickey7*. Starring Robert Pattinson,...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok